Latest filing published 10 Jan 2018 for Immune Design Corp., €65k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Leo Guthart: trading record in brief
This profile gathers the share dealings of Leo Guthart across 2 companies, led by Immune Design Corp. and Aptargroup, Inc. Between 4 January 2007 and 8 January 2018, the trades on record add up to 20 filings.
Market trades split into 15 purchases (€9.2M) and 1 sale (€628k). Taken together, the purchases exceed the sales by €8.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 option exercises. 2018 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €39k. Of 15 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 10 January 2018, reports an open-market purchase of €65k in Immune Design Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Leo Guthart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$3.900.7% of flowCommon StockSEC:0001144204-18-001673:0Canonical exit: 8 Apr 2018 (T+90)
- 2,500 shares0Common StockSEC:0001144204-17-055242:1
- 2,439,000 shares@ US$4.1093.5% of flowCommon StockSEC:0001144204-17-055242:0Canonical exit: 25 Jan 2018 (T+90)
- 10,000 shares@ US$5.260.5% of flowCommon StockSEC:0001144204-17-053790:0Canonical exit: 18 Jan 2018 (T+90)
- 10,000 shares@ US$5.250.5% of flowCommon StockSEC:0001144204-17-053790:1Canonical exit: 18 Jan 2018 (T+90)
- 20,000 shares@ US$4.350.8% of flowCommon StockSEC:0001144204-17-053790:2Canonical exit: 22 Jan 2018 (T+90)
- 10,000 shares@ US$4.350.4% of flowCommon StockSEC:0001144204-17-053790:3Canonical exit: 22 Jan 2018 (T+90)
- 10,000 shares@ US$4.340.4% of flowCommon StockSEC:0001144204-17-053790:4Canonical exit: 22 Jan 2018 (T+90)
- 2,344 shares@ US$6.400.1% of flowCommon StockSEC:0001144204-17-053397:0Canonical exit: 16 Jan 2018 (T+90)
- 7,656 shares@ US$6.000.4% of flowCommon StockSEC:0001144204-17-053397:1Canonical exit: 17 Jan 2018 (T+90)
- 10,000 shares@ US$9.700.9% of flowCommon StockSEC:0001144204-17-049226:0Canonical exit: 17 Dec 2017 (T+90)
- 4,730 shares@ US$6.120.3% of flowCommon StockSEC:0001144204-17-028951:0Canonical exit: 7 Aug 2017 (T+90)
- 13,270 shares@ US$6.070.8% of flowCommon StockSEC:0001144204-17-028951:1Canonical exit: 7 Aug 2017 (T+90)
- 6,000 shares@ US$6.060.4% of flowCommon StockSEC:0001144204-17-028951:2Canonical exit: 7 Aug 2017 (T+90)
- 1,000 shares@ US$6.050.1% of flowCommon StockSEC:0001144204-17-028951:3Canonical exit: 7 Aug 2017 (T+90)
- 5,000 shares@ US$6.140.3% of flowCommon StockSEC:0001144204-17-028951:4Canonical exit: 8 Aug 2017 (T+90)
- 16,000 shares@ US$25.67Common StockSEC:0001200183-12-000003:0
- 16,000 shares@ US$52.88Common StockSEC:0001200183-12-000003:1
- 16,000 shares@ US$17.20Common StockSEC:0001200183-11-000001:0
- 8,000 shares@ US$20.88Common StockSEC:0001200183-07-000001:0
20 of 20 declarations
